Figure 3A shows that hub DEIRGs (e.g., PROCR (p = 0.039), S100A12 (p = 0.019), SLC22A17 (p = 0.011)) significantly affected the overall survival outcomes of STAD patients. The gene discussed is S100A12; the disease is gastric adenocarcinoma.